CHIRAL METHODOLOGY Asymmetric Reactions – Part One

0.0(0)
studied byStudied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/20

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:13 PM on 2/7/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

21 Terms

1
New cards

What is asymmetric hydrogenation and why is it industrially important?

Adding H₂ across C=C, C=O, or C=N using chiral metal catalysts. Important due to high efficiency (TON/TOF), high ee, and industrial scalability

2
New cards

What variables must be optimized in asymmetric hydrogenation?

Hydrogen source, pressure, temperature, solvent, metal (Rh, Ru, Ir), and chiral ligand.

3
New cards

How can you make a chiral reducing agent from LiAlH₄?

Add a chiral diol and a simple alcohol (ROH) to form a chiral aluminum hydride complex for enantioselective carbonyl reduction.

4
New cards

What is atropisomerism and how does it create chirality?

Chirality from restricted rotation around a single bond (e.g., in biphenyls with bulky ortho substituents). Results in non-superimposable mirror images

5
New cards
<p>i<span><span>n the example shown, which atropisomer is more expensive and why?</span></span></p>

in the example shown, which atropisomer is more expensive and why?

he (R)-enantiomer (clockwise twist) is more expensive — likely due to being the biologically active form or harder to synthesize.

6
New cards

What is BINAL-H and how does it achieve high enantioselectivity?

Chiral reducing agent from BINOL + AlH₃. Works via a chair-like 6-membered transition state that controls hydride delivery to one face of the carbonyl.

7
New cards

What causes the high selectivity in BINAL-H reductions?

n-π repulsion between the ketone’s alkyl group and BINOL’s aromatic system disfavors one transition state, favoring the other.

8
New cards

Name four chiral catalysts/reagents and their uses.

  1. CBS reagent – ketone reduction

  2. Alpine-Borane – alkyne reduction

  3. Ru-BINAP-diamine – asymmetric hydrogenation (Noyori)

  4. DIP-Chloride – stereoselective reduction (Brown)

9
New cards

How does Alpine-Borane achieve stereoselective alkyne reduction?

The bulky α-pinene group blocks one face of the alkyne, directing hydride delivery to the less hindered side

10
New cards

What are two methods for asymmetric imine reduction?

  1. Iridium-catalyzed H₂ hydrogenation (high pressure, >99% ee)

  2. Transfer hydrogenation with HCOOH/NEt₃ (no high pressure, 97% ee)

11
New cards

If a reaction gives 32% ee in favor of S, what is the % of R?

34% R (S = 66%, R = 50 – 16 = 34%)

12
New cards

Why does replacing isopropyl with phenyl increase ee?

Phenyl is larger, rigid, and engages in extra steric/electronic interactions with the catalyst, improving facial discrimination.

13
New cards

How can you separate enantiomers after a reaction?

  1. Chiral column chromatography

  2. diastereomeric salt formation,

  3. kinetic resolution.

14
New cards

What is the stereochemical outcome of SN2 vs SN1 reactions?

SN2 = Inversion (backside attack). SN1 = Racemic mixture (carbocation intermediate).

15
New cards

What does the Mitsunobu reaction guarantee?

SN2 substitution with complete inversion of configuration at alcohols.

16
New cards

What two reagents are essential for the classic Mitsunobu reaction?

  1. PPh₃ (triphenylphosphine)

  2. DEAD (diethyl azodicarboxylate)

17
New cards

What are the byproducts of the Mitsunobu reaction and why do they matter?

O=PPh₃ (stable) and reduced DEAD. The strong P=O bond formation drives the reaction forward.

18
New cards

What type of nucleophile is required for Mitsunobu and why?

Acidic nucleophile (pKa < 15) so it can be deprotonated to become a good attacking Nu⁻

19
New cards

Give three examples of Mitsunobu nucleophiles.

Carboxylic acids (pKa ~4-5), phenols (pKa ~10), phthalimide (pKa ~8-9)

20
New cards

Why is the 2019 Mitsunobu advancement important for drug discovery?

Greener, safer, higher atom economy, no toxic byproducts, easier scale-up for pharmaceutical synthesis

21
New cards

How does chiral catalysis relate to drug safety?

One enantiomer may be therapeutic; the other may be toxic or inactive. Asymmetric synthesis ensures high ee of the active form.